Chain of custody, manufacturing coordination, and site workflows that keep cell and gene therapy studies moving
In cell and gene therapy trials, logistics are more than an operational consideration. A missed collection, delayed shipment, manufacturing issue, or temperature excursion can disrupt dosing timelines, increase site burden, and affect the patient experience.
This infographic highlights how coordinated handoffs across the patient journey can help reduce avoidable delays and support more predictable CGT trial execution, from patient readiness and site scheduling to manufacturing coordination, product return, pharmacy preparation, and bedside administration.
WHAT’S INSIDE:
Explore key logistics risks and readiness considerations shaping CGT trial execution, including:
- Chain of identity and chain of custody requirements from collection through infusion
- Manufacturing slot limitations and their impact on enrollment timing
- Courier coordination, cold chain requirements, and temperature excursion planning
- Multi-stakeholder scheduling across sponsors, sites, manufacturers, couriers, and CROs
- Five readiness areas that help reduce risk
